FGP
EMN icon

Freestone Grove Partners’s Eastman Chemical EMN Stock Holding History

Freestone Grove Partners’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$954K Sell
14,240
-10,609
-43% -$776K 0.01% 549
2026
Q1 		$1.9M Buy
24,849
+13,326
+116% +$961K 0.01% 378
2025
Q4 		$736K Sell
11,523
-14,323
-55% -$883K 0.01% 504
2025
Q3 		$1.63M Buy
+25,846
New +$1.8M 0.01% 387
2025
Q1 		– Sell
-6,124
Closed -$559K – 648
2024
Q4 		$559K Buy
+6,124
New +$628K 0.01% 366

Other funds holding EMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Freestone Grove Partners's EMN Position: Q2 2026 in Review

Freestone Grove Partners reduced its Eastman Chemical (EMN) stake by 43% in Q2 2026, selling an estimated $776K and leaving 14,240 shares worth $954K. The position accounts for 0.01% of the portfolio, ranked #549.

Freestone Grove Partners first reported a position in EMN in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.9M in Q1 2026. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Freestone Grove Partners held 14,240 shares of Eastman Chemical worth $954K as of Q2 2026.
  • Freestone Grove Partners sold 10,609 Eastman Chemical shares in Q2 2026, an estimated $776K.
  • Eastman Chemical made up 0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #549 holding.
  • Freestone Grove Partners first reported a position in Eastman Chemical in Q4 2024 and has held it in 5 quarters since.
  • Freestone Grove Partners's Eastman Chemical position peaked at $1.9M in Q1 2026.
  • 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.